142 related articles for article (PubMed ID: 20207170)
1. Lung transplantation under a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen results in low titers of HLA and MICA IgG antibodies which are not related to development of BOS.
Paantjens AW; van de Graaf EA; van Ginkel WG; van den Bosch JM; Otten HG
J Heart Lung Transplant; 2010 May; 29(5):596-8. PubMed ID: 20207170
[No Abstract] [Full Text] [Related]
2. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to human leukocyte antigens in lung transplantation.
Hachem RR
Clin Transpl; 2011; ():327-32. PubMed ID: 22755426
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation.
Neurohr C; Huppmann P; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Uberfuhr P; Bittmann I; Behr J; Reichart B;
Transpl Int; 2009 Jun; 22(6):635-43. PubMed ID: 19207186
[TBL] [Abstract][Full Text] [Related]
5. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant presence of antibodies to MICA and HLA class I or II are associated with an earlier onset of bronchiolitis obliterans syndrome in lung transplant recipients.
Lyu DM; Grazia TJ; Benson AB; Cagle LR; Freed BM; Zamora MR
Clin Transpl; 2012; ():237-46. PubMed ID: 23721028
[TBL] [Abstract][Full Text] [Related]
7. Lung transplants with tacrolimus and mycophenolate mofetil: a review.
Lama R; Santos F; Algar FJ; Alvarez A; Baamonde C
Transplant Proc; 2003 Aug; 35(5):1968-73. PubMed ID: 12962866
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of rescue therapy with tacrolimus and mycophenolate mofetil in lung transplanted patients with bronchiolitis obliterans.
Roman A; Bravo C; Monforte V; Reyes L; Canela M; Morell F
Transplant Proc; 2002 Feb; 34(1):146-7. PubMed ID: 11959227
[No Abstract] [Full Text] [Related]
9. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
[TBL] [Abstract][Full Text] [Related]
10. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
[TBL] [Abstract][Full Text] [Related]
11. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
[TBL] [Abstract][Full Text] [Related]
12. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
[No Abstract] [Full Text] [Related]
13. Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation.
Angaswamy N; Saini D; Ramachandran S; Nath DS; Phelan D; Hachem R; Trulock E; Patterson GA; Mohanakumar T
Hum Immunol; 2010 Jun; 71(6):560-5. PubMed ID: 20211214
[TBL] [Abstract][Full Text] [Related]
14. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
15. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
16. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
Peng ZG; Tian J
Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
[TBL] [Abstract][Full Text] [Related]
17. Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients.
Ciancio G; Burke GW; Suzart K; Mattiazzi A; Rosen A; Zilleruello G; Abitbol C; Montane B; Miller J
Transplant Proc; 2002 Aug; 34(5):1944-5. PubMed ID: 12176637
[No Abstract] [Full Text] [Related]
18. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation.
Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Hallar M; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Transpl Immunol; 2008 Nov; 20(1-2):61-7. PubMed ID: 18929659
[TBL] [Abstract][Full Text] [Related]
19. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
